Taiwan FDA registration 60b3ecc735f05633d6cb39ae80329f21
"Epter" Bredeen is a combination of vein-hepatic pathways
TW: “埃普特” 布雷丁經頸靜脈肝臟通路套組
Taiwan·Risk Class 2·APT Medical Inc.·Registered Mar 01, 2024 – Mar 01, 2029ActiveRegistration details
- Analysis ID
- 60b3ecc735f05633d6cb39ae80329f21
- Customs Code
- DHA09200151903
Company information
- Manufacturer
- APT Medical Inc.
- Manufacturer Country
- China
- Authorized Representative
- NO.1 BIOTECHNOLOGY CO., LTD.
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- E Cardiovascular Medicine Science
- Product Type (Level 2)
- E.1340 Catheter Introducers
- Import Information
- Input;; Chinese goods
Dates and status
- Registration Date
- Mar 01, 2024
- Expiry Date
- Mar 01, 2029
About this record
Access comprehensive regulatory information for "Epter" Bredeen is a combination of vein-hepatic pathways in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 60b3ecc735f05633d6cb39ae80329f21 and manufactured by APT Medical Inc.. The authorized representative in Taiwan is NO.1 BIOTECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices